These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7345095)

  • 21. Multiple dose kinetics and drug dosage in patients with kidney disease.
    Dettli L; Spring P; Ryter S
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():211-24. PubMed ID: 5316403
    [No Abstract]   [Full Text] [Related]  

  • 22. Simple approach to dosage adjustment in patients with renal impairment.
    McCormack JP; Cooper J; Carleton B
    Am J Health Syst Pharm; 1997 Nov; 54(21):2505-9. PubMed ID: 9359960
    [No Abstract]   [Full Text] [Related]  

  • 23. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
    Vidal L; Shavit M; Fraser A; Paul M; Leibovici L
    BMJ; 2005 Jul; 331(7511):263. PubMed ID: 15905228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing reimbursable clinical pharmacy programs: pharmacokinetic dosing service.
    Moore TD; Schneider PJ; Nold EG
    Am J Hosp Pharm; 1979 Nov; 36(11):1523-7. PubMed ID: 517538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Prediction of drug elimination in renal disease based on drug concentration measurements in plasma and/or urine.
    Dettli L
    Arzneimittelforschung; 1976; 26(6):1254. PubMed ID: 989451
    [No Abstract]   [Full Text] [Related]  

  • 27. The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance.
    Miners JO; Yang X; Knights KM; Zhang L
    Clin Pharmacol Ther; 2017 Sep; 102(3):436-449. PubMed ID: 28599065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic analysis of gentamicin dosage regimens recommended for renal impairment.
    Schumacher GE
    J Clin Pharmacol; 1975 Oct; 15(10):656-65. PubMed ID: 1184769
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
    Khanal A; Castelino RL; Peterson GM; Jose MD
    Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. III. Effects of dosage adjustment method.
    Rogers RA; Hanna AY; Riviere JE
    Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):301-11. PubMed ID: 3671882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical pharmacokinetic techniques for drug consultation and evaluation. II. A perspective on the renal impaired patient.
    Schumacher GE
    Am J Hosp Pharm; 1973 Sep; 30(9):824-30. PubMed ID: 4582138
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug dosing in patients with renal insufficiency. A simplified approach.
    Bakris GL; Talbert R
    Postgrad Med; 1993 Dec; 94(8):153-6, 159-60, 163-4. PubMed ID: 8247992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A package of computer programs designed to simulate pharmacokinetic monitoring of drug therapy.
    Sullivan TJ; Wunderley DJ
    Comput Programs Biomed; 1980 Dec; 12(2-3):85-95. PubMed ID: 7249607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer assisted prescribing of drugs.
    Mawer GE
    Clin Pharmacokinet; 1976; 1(1):67-78. PubMed ID: 797493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of creatinine in man and its implications in the monitoring of renal function and in dosage regimen modifications in patients with renal insufficiency.
    Chiou WL; Hsu FH
    J Clin Pharmacol; 1975; 15(5-6):427-34. PubMed ID: 1133219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs.
    Peterson JP; Colucci VJ; Schiff SE
    Am J Hosp Pharm; 1991 Sep; 48(9):1962-4. PubMed ID: 1928141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dosage in patients with renal failure optimized by immediate concurrent feedback.
    Falconnier AD; Haefeli WE; Schoenenberger RA; Surber C; Martin-Facklam M
    J Gen Intern Med; 2001 Jun; 16(6):369-75. PubMed ID: 11422633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inappropriate drug dosage adjustments in patients with renal impairment.
    Markota NP; Markota I; Tomic M; Zelenika A
    J Nephrol; 2009; 22(4):497-501. PubMed ID: 19662605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.